Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-17 Purchase |
2025-03-18 7:01 pm |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
200,000 | $0.5581 | $111,620 | 372,725 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-10 Option Award |
2025-02-26 7:29 pm |
N/A 2035-02-09 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
618,750 | $0 | 678,975 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-12 6:52 pm |
N/A 2034-06-10 |
2seventy bio Inc. | TSVT | Newton Charles W. Director |
18,075 | $0 | 34,675 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:52 pm |
N/A 2034-06-03 |
Coherus BioSciences Inc. | CHRS | Newton Charles W. Director |
112,000 | $0 | 112,000 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-25 4:28 pm |
N/A 2034-03-20 |
2seventy bio Inc. | TSVT | Newton Charles W. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 8:19 pm |
N/A 2034-02-08 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
440,000 | $0 | 448,729 (Direct) |
View |
| 2023-11-16 Option Award |
2023-11-20 8:55 pm |
N/A 2031-02-04 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
4,818,000 | $0 | 4,826,729 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:56 pm |
N/A 2033-06-07 |
Coherus BioSciences Inc. | CHRS | Newton Charles W. Director |
38,250 | $0 | 38,250 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 6:13 pm |
N/A 2033-02-23 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
700,000 | $0 | 702,941 (Direct) |
View |
| 2022-05-04 Option Award |
2022-05-06 6:50 pm |
N/A 2032-05-04 |
Coherus BioSciences Inc. | CHRS | Newton Charles W. Director |
54,000 | $0 | 54,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:09 pm |
N/A 2032-03-15 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership |
2021-06-16 7:21 pm |
N/A 2031-02-04 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
0 | $0 | 4,318,000 (Direct) |
View |